TL;DR — Aging mitochondria produce less ATP, leak more ROS, and fail to clear damage. NAD+ decline is the central bottleneck. Track energy + resting heart rate; intervene with NAD+A molecule every cell needs for energy production, DNA repair, and activating longevity genes (sirtuins). Full glossary → restoration, mitophagyA specific form of autophagy that selectively removes damaged or dysfunctional mitochondria, replacing them with healthy ones. Full glossary → support, and antioxidant substrate — in that order of leverage.
What this hallmark means
Mitochondria are not static batteries. They fuse, divide, export metabolites, and get recycled through mitophagy. With age, three failures compound:
| Failure mode | What changes | What you feel |
|---|---|---|
| NAD+ depletion | ~50% drop between ages 40–60; starves SIRT3, PARP, and CD38 | Afternoon crashes, slower recovery |
| Biogenesis stall | PGC-1α signaling weakens; fewer new mitochondria | Endurance plateaus despite training |
| Mitophagy backlog | Damaged organelles accumulate; membrane potential drops | Brain fog, elevated resting HR |
The metabolic signature: less oxidative phosphorylation, more glycolysis — even in well-oxygenated tissue. Cells run "dirty" energy production.
Hallmark 6 · Mitochondrial dysfunction
Both a primary hallmark and an amplifier — poor mito output increases ROS, which accelerates genomic instability (H1), proteostasis collapse (H4), and chronic inflammation (H10).
Why this matters for your protocol
This is the hallmark with the highest TNiC stack coverage (95%) because core compounds directly target the NAD+ → sirtuin → mitophagy axis — not peripheral symptoms.
Intervention hierarchy (evidence-weighted):
- Lifestyle foundation — Zone 2 cardio and sleep are the only interventions with mortality data at scale
- NAD+ substrate — NMN/NR restores the coenzyme pool that powers SIRT3-mediated mitophagy
- Antioxidant substrate — GlyNAC protects existing mitochondria from ROS while biogenesis catches up
- Biogenesis signal — Resveratrol → SIRT1 → PGC-1α (weaker standalone human data; stronger as stack leg)
Rajman et al. Cell Metabolism 2018 (PMID 29514064) — NAD+ intermediates restore mitochondrial function in aged tissue. López-Otín et al. Cell 2023 (PMID 36599349) — mitochondrial dysfunction remains a core, actionable hallmark in the updated framework.
Practical intervention map
| Lever | Mechanism | Evidence | TNiC resource |
|---|---|---|---|
| NMN / NR | ↑ NAD+ → SIRT3 → mitophagy | Tier A (human NAD+ elevation) | NMN compound guide |
| GlyNAC | Mito GSH pool protects Complex I/III | Tier A (24-wk RCT) | GlyNAC guide |
| Ca-AKG | TCA cycle flux + epigenetic support | Tier A preclinical / B human | NAD+ Mito Stack |
| Zone 2 exercise | PGC-1α biogenesis (free) | Tier A (mortality) | Exercise protocol |
| Sleep optimization | Mitophagy peaks in deep sleep | Tier A (mortality) | Sleep protocol |
← Swipe for more columns →
Your 90-day mitochondrial protocol
Weeks 1–4 (foundation): Log morning energy (1–10) and resting HR. Add 150 min/week Zone 2. Fix sleep timing before any supplement spend.
Weeks 5–12 (substrate): Add NMN 250–500 mg AM fasted. Optional GlyNAC 600/600 if oxidative stressAn imbalance between reactive oxygen species (free radicals) produced by metabolism and the antioxidant systems that neutralize them. Full glossary → markers elevated.
Weeks 13–24 (stack): Layer NAD+ Mito Stack or NRF2 Defense Triad based on biomarker gaps — not both on day one.
Decision point at week 12: NAD+ index up + energy ↑2 points → continue. Flat biomarkers + flat energy → audit compliance and sleep before escalating dose.
Which mito intervention first?
Are sleep (7+ hrs) and Zone 2 (150 min/wk) consistent for 4+ weeks?
node | Is NAD+ index below 80 OR energy score ≤5/10?
Start NMN 250 mg AM fasted → retest NAD+ at week 4
node | Are GSH or hs-CRP off-target?
Add GlyNAC 600/600 → consider NRF2 triad at week 12
Maintain lifestyle; retest quarterly
Fix sleep + exercise first → supplements are low-leverage until foundation is stable
Chest pain, unexplained syncope, or rhabdomyolysis history → physician clearance before NAD+ or exercise escalation
Educational decision aid — a way to organize the evidence, not a prescription. Doses and timing shown are those used in studies; confirm anything you act on with a clinician or pharmacist.
What to measure
| Signal | Type | Frequency | Success looks like |
|---|---|---|---|
| Morning energy | Subjective (1–10) | Daily | ↑2 points sustained over 4 weeks |
| Resting heart rate | Wearable proxy | Daily | ↓2–5 bpm over 12 weeks |
| NAD+ index | Lab | Baseline, 4 wk, 12 wk | 80–100 range |
| Fasting glucose | Lab | 3 months | <100 mg/dL |
| hs-CRP | Lab | 12 wk | <1.0 mg/L (inflammation-mito link) |
← Swipe for more columns →
Subjective energy
5/10
Resting HR
68 bpm
NAD+ index
62
Recovery score (wearable)
Low
Subjective energy
7/10
Resting HR
63 bpm
NAD+ index
85+
Recovery score (wearable)
Moderate+
Track mito biomarkers
Log NAD+, glucose, and hs-CRP to see optimal/watch/critical status over time.
Open Labs hubRed flags — when to pause or escalate to a physician
Stop and consult before intensifying
- Unexplained muscle pain or weakness worsening with exercise or NMN — rule out metabolic myopathy
- Resting HR rising despite improved fitness — arrhythmia or thyroid; don't mask with more supplements
- Fasting glucose rising on NAD+ precursors — paradoxical insulin resistance; physician review
- Active cancer treatment — NAD+ and antioxidant stacks may interfere; oncologist clearance required
- Pregnancy or breastfeeding — insufficient safety data for most mito interventions
Synergies worth knowing
| Stack | Covers | Best for |
|---|---|---|
| NAD+ Mito Stack | Biogenesis + NAD+ + mitophagy | Primary mito hallmark coverage |
| NRF2 Defense Triad | Antioxidant + gene induction | Elevated oxidative stress / GSH low |
| GlyNAC + NMN | Orthogonal axes (GSH + NAD+) | Full redox + repair coverage |
Build your mito stack
Toggle NMN, GlyNAC, and resveratrol — synergyWhen two compounds together produce greater effect than either alone. Full glossary → score updates with contraindication checks.
Open Stack ArchitectPersonal results template
My mitochondrial dysfunction log
Copy into your notes app or Labs hub. Update weekly for subjective metrics; labs at baseline, week 12, week 24.
| Date | Week | Energy (1–10) | RHR | Sleep (hrs) | Zone 2 (min/wk) | NAD+ | Glucose | hs-CRP | Stack notes |
|---|---|---|---|---|---|---|---|---|---|
| YYYY-MM-DD | 0 | — | — | — | — | — | — | — | Baseline only |
| YYYY-MM-DD | 4 | — | — | — | — | — | — | — | Post-NMN start |
| YYYY-MM-DD | 12 | — | — | — | — | — | — | — | Primary endpoint |
| YYYY-MM-DD | 24 | — | — | — | — | — | — | — | Maintenance review |
← Swipe for more columns →
Personal response criteria: - Meaningful: Energy ↑2+ AND (NAD+ in range OR RHR ↓3 bpm) - Plateau: Flat at week 12 → audit sleep compliance before adding compounds - Adverse: RHR rising or glucose worsening → pause stack, physician consult
Further reading
- López-Otín et al. Cell 2023 — Updated hallmarks framework (PMID 36599349)
- Rajman et al. Cell Metabolism 2018 — Therapeutic approaches to NAD+ restoration (PMID 29514064)
- Picard & McEwen. Cell Metabolism 2018 — Mitochondrial allostatic load and stress
References
Links open PubMed. TNiC does not sell supplements; citations support education, not medical advice.